Patents by Inventor Robert Devlin Carlson

Robert Devlin Carlson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Desmoglein 2-directed chimeric antigen receptor (CAR) constructs and methods of use
    Patent number: 12758632
    Abstract: The present disclosure relates to Dsg2 binding molecules, nucleic acid molecules encoding the Dsg2 binding molecules and compositions comprising the same and methods of use thereof for treating or preventing cancer.
    Type: Grant
    Filed: December 2, 2021
    Date of Patent: October 13, 2026
    Assignee: Thomas Jefferson University
    Inventors: Adam Eugene Snook, My Georgia Mahoney, Robert Devlin Carlson
  • Desmoglein 2-directed chimeric antigen receptor (CAR) constructs and methods of use
    Publication number: 20240108651
    Abstract: The present disclosure relates to Dsg2 binding molecules, nucleic acid molecules encoding the Dsg2 binding molecules and compositions comprising the same and methods of use thereof for treating or preventing cancer.
    Type: Application
    Filed: December 2, 2021
    Publication date: April 4, 2024
    Inventors: Adam Eugene Snook, My Georgia Mahoney, Robert Devlin Carlson